Literature DB >> 1728613

Cancer control programme in India: opportunities for implementation and evaluation.

R Sankaranarayanan1, M K Nair, B Mathew, R Wesley, S Mayadevi.   

Abstract

Cancer is now being appreciated in India as an emerging public health problem. Approximately 600,000 new cancer cases occur in India every year, and the absolute number of new cancer patients will increase considerably, due to growth in the size of the population and an increase in the proportion of elderly persons due to improved life expectancy following control of communicable diseases. This emerging problem has received the attention of the Government of India, and some state governments within the Indian Federation have formulated National and State Cancer Control Programmes to deal with the situation. In the event of these programmes being implemented, consideration should be given now to measures of evaluation of the activities, as many of the indices, used to monitor programmes in developed countries, such as 15% reduction from peak cancer mortality, or in peak mortality from specific cancers, are not applicable in developing countries like India. Factors such as the pattern of tobacco habits in the community, knowledge, attitude and practice (KAP) patterns regarding cancer in the general population, referral practices, and the national pattern of extent of disease at presentation, gain considerable importance from the evaluation point of view. Our article mainly deals with the sources and the quality of baseline data for such factors and the realistic quantitative goals which could be set for the above factors.

Entities:  

Mesh:

Year:  1992        PMID: 1728613     DOI: 10.1002/ijc.2910500112

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  1 in total

1.  Cervical cancer in Kerala: a hospital registry-based study on survival and prognostic factors.

Authors:  R Sankaranarayanan; M K Nair; P G Jayaprakash; G Stanley; C Varghese; V Ramadas; G Padmakumary; T K Padmanabhan
Journal:  Br J Cancer       Date:  1995-10       Impact factor: 7.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.